/cdsr/doi/10.1002/14651858.CD002777.pub2/full|High versus low medium chain triglyceride content of formula for promoting short‐term growth of preterm infants|/cdsr/doi/10.1002/14651858.CD011293.pub3/full|Sublingual immunotherapy for asthma|/cdsr/doi/10.1002/14651858.CD007263.pub3/full|Dilute versus full‐strength formula in exclusively formula‐fed preterm or low birth weight infants|/cdsr/doi/10.1002/14651858.CD006135.pub3/full|Probiotics for treating eczema|/cdsr/doi/10.1002/14651858.CD003664.pub6/full|Infant formulas containing hydrolysed protein for prevention of allergic disease|/cdsr/doi/10.1002/14651858.CD008263.pub3/full|Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis|/cdsr/doi/10.1002/14651858.CD012597.pub2/full|Saline irrigation for allergic rhinitis|/cdsr/doi/10.1002/14651858.CD004414.pub3/full|Interventions for preventing occupational irritant hand dermatitis|/cdsr/doi/10.1002/14651858.CD010638.pub3/full|Oral and sublingual immunotherapy for egg allergy|/cdsr/doi/10.1002/14651858.CD010288.pub4/full|Anti‐IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis|/cdsr/doi/10.1002/14651858.CD002204.pub4/full|Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis|/cdsr/doi/10.1002/14651858.CD010112.pub2/full|Polyunsaturated fatty acid supplementation in infancy for the prevention of allergy|/cdsr/doi/10.1002/14651858.CD008774.pub2/full|Specific allergen immunotherapy for the treatment of atopic eczema|/cdsr/doi/10.1002/14651858.CD009745.pub2/full|Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion|/cdsr/doi/10.1002/14651858.CD010522.pub2/full|Immunotherapy (oral and sublingual) for food allergy to fruits|/cdsr/doi/10.1002/14651858.CD010464.pub2/full|Glycerin laxatives for prevention or treatment of feeding intolerance in very low birth weight infants|/cdsr/doi/10.1002/14651858.CD010085.pub2/full|Maternal prenatal and/or postnatal n‐3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood|/cdsr/doi/10.1002/14651858.CD009566.pub2/full|Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis|/cdsr/doi/10.1002/14651858.CD008426.pub2/full|House dust mite reduction and avoidance measures for treating eczema|/cdsr/doi/10.1002/14651858.CD006137.pub2/full|H1‐antihistamines for chronic spontaneous urticaria|/cdsr/doi/10.1002/14651858.CD003559.pub4/full|Omalizumab for asthma in adults and children|/cdsr/doi/10.1002/14651858.CD003563.pub2/full|Dehumidifiers for chronic asthma|/cdsr/doi/10.1002/14651858.CD006474.pub3/full|Prebiotics in infants for prevention of allergy|/cdsr/doi/10.1002/14651858.CD004591.pub3/full|Lactase treated feeds to promote growth and feeding tolerance in preterm infants|/cdsr/doi/10.1002/14651858.CD007770.pub2/full|Oral H1 antihistamines as monotherapy for eczema|